
pmid: 27160799
Glucagon-like peptide (GLP)-1 receptor agonists enhance insulin secretion and may improve pancreatic islet cell function. However, GLP-1 receptor (GLP-1R) agonist treatment may have more complex, and sometimes deleterious, effects on beta cells. We discuss the concepts of beta cell protection versus exhaustion for different GLP-1R agonists based on recent data.
Glucagon-Like Peptide-1 Receptor Agonists, Glucagon-Like Peptide 1, Insulin-Secreting Cells, Journal Article, Animals, Humans, Insulin, Glucagon-Like Peptide-1 Receptor, Signal Transduction
Glucagon-Like Peptide-1 Receptor Agonists, Glucagon-Like Peptide 1, Insulin-Secreting Cells, Journal Article, Animals, Humans, Insulin, Glucagon-Like Peptide-1 Receptor, Signal Transduction
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 15 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
